Home LiteratureArticle Details
PMID: 7911787 Published · ppublish English Comparative Study Journal Article Research Support, Non-U.S. Gov't

Role of antibodies against biotype-specific Vibrio cholerae pili in protection against experimental classical and El Tor cholera.

Infection and immunity ·Vol. 62 ·No. 7 ·1994-07-00 ·Pages 2901-7

Osek J, Jonson G, Svennerholm AM, Holmgren J

Abstract

Vibrio cholerae O1, which exists as two biotypes, classical and El Tor, expresses fimbrial antigens called toxin-coregulated pili (TCP) and mannose-sensitive hemagglutinin (MSHA) pili, respectively. We have raised rabbit antisera and monoclonal antibodies against these fimbrial antigens and prepared Fab fragments which possess specific antibodies directed against the respective fimbrial antigens from these antisera. The protective effect of these antibody preparations was studied in the infant mouse cholera model. Antibodies against TCP were able to protect baby mice against challenge with V. cholerae O1 of the classical but not of the El Tor biotype. Similar but reverse biotype differences in protection against challenge with classical and El Tor vibrios were observed when antibodies against MSHA pili were used. The protective effect of V. cholerae O1 antilipopolysaccharide (anti-LPS) antibodies, both alone and in combination with antifimbrial antibodies, was also evaluated. We showed that antibodies to the LPS component also prevented infections with V. cholerae O1. Moreover, our results indicate that antibodies against TCP or MSHA pili and against LPS cooperate at least additively, and possible even synergistically, in protecting baby mice against challenge with group O1 vibrios. These results indicate that TCP and MSHA pili as well as LPS play an important role in the pathogenesis of experimental cholera. We could also demonstrate that antibacterial immunity preventing colonization is biotype specific. Our results might be used for the generation of new oral cholera vaccines including both TCP and MSHA fimbrial antigens.

MeSH Terms
Animals Animals, Newborn Antibodies, Bacterial/therapeutic use Antibody Specificity Cholera/etiology,prevention & control Cholera Toxin/pharmacology Disease Models, Animal Drug Synergism Fimbriae, Bacterial/classification,immunology Immunization, Passive Immunoglobulin Fab Fragments/therapeutic use Lipopolysaccharides/immunology Mannose/pharmacology Mice Species Specificity
Chemicals
Antibodies, Bacterial Immunoglobulin Fab Fragments Lipopolysaccharides Cholera Toxin Mannose
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Osek J
Department of Medical Microbiology and Immunology, University of Göteborg, Sweden.
Jonson G
Svennerholm A M
Holmgren J
References (32)
32 references, click to expand
  1. Experimental studies on cholera immunization. 4. The antibody response to formalinized Vibrio cholerae and purified endotoxin with special reference to protective capacity.
    Int Arch Allergy Appl Immunol. 1975;49(4):434-52 PMID: 808500
  2. The hydrolysis of rabbit y-globulin and antibodies with crystalline papain.
    Biochem J. 1959 Sep;73:119-26 PMID: 14434282
  3. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.
    Anal Biochem. 1976 May 7;72:248-54 PMID: 942051
  4. Intestinal fluid accumulation induced by oral challenge with Vibrio cholerae or cholera toxin in infant mice.
    Infect Immun. 1977 Mar;15(3):704-12 PMID: 870427
  5. Development of improved cholera vaccine based on subunit toxoid.
    Nature. 1977 Oct 13;269(5629):602-4 PMID: 72361
  6. Production of monoclonal antibodies: strategy and tactics.
    J Immunol Methods. 1980;35(1-2):1-21 PMID: 7009747
  7. Actions of cholera toxin and the prevention and treatment of cholera.
    Nature. 1981 Jul 30;292(5822):413-17 PMID: 7019725
  8. Characterization and distribution of the hemagglutinins produced by Vibrio cholerae.
    Infect Immun. 1982 Apr;36(1):209-14 PMID: 7076294
  9. Oral immunization of dogs with purified cholera toxin, crude cholera toxin, or B subunit: evidence for synergistic protection by antitoxic and antibacterial mechanisms.
    Infect Immun. 1982 Aug;37(2):687-94 PMID: 6889574
  10. The role of the flagellum in the adherence of Vibrio cholerae.
    J Infect Dis. 1983 May;147(5):864-72 PMID: 6842021
  11. Culture conditions for stimulating cholera toxin production by Vibrio cholerae O1 El Tor.
    Microbiol Immunol. 1986;30(11):1075-83 PMID: 3543624
  12. Nonlipopolysaccharide protective antigens shared by classical and El Tor biotypes of Vibrio cholerae.
    J Infect Dis. 1987 Apr;155(4):716-23 PMID: 3819476
  13. Use of phoA gene fusions to identify a pilus colonization factor coordinately regulated with cholera toxin.
    Proc Natl Acad Sci U S A. 1987 May;84(9):2833-7 PMID: 2883655
  14. Purification and partial characterization of fimbriae of Vibrio cholerae O1.
    Vaccine. 1987 Dec;5(4):283-8 PMID: 2448968
  15. Demonstration of lipopolysaccharide on sheathed flagella of Vibrio cholerae O:1 by protein A-gold immunoelectron microscopy.
    J Bacteriol. 1988 Apr;170(4):1488-94 PMID: 2450866
  16. Toxin, toxin-coregulated pili, and the toxR regulon are essential for Vibrio cholerae pathogenesis in humans.
    J Exp Med. 1988 Oct 1;168(4):1487-92 PMID: 2902187
  17. Morphological studies on fimbriae expressed by Vibrio cholerae 01.
    Microb Pathog. 1988 Apr;4(4):257-65 PMID: 2904642
  18. Expression and detection of different biotype-associated cell-bound haemagglutinins of Vibrio cholerae O1.
    J Gen Microbiol. 1989 Jan;135(1):111-20 PMID: 2674322
  19. Significance of toxin-coregulated pili as protective antigens of Vibrio cholerae in the infant mouse model.
    Vaccine. 1989 Oct;7(5):451-6 PMID: 2573216
  20. Field trial of oral cholera vaccines in Bangladesh: results from three-year follow-up.
    Lancet. 1990 Feb 3;335(8684):270-3 PMID: 1967730
  21. Antibodies directed against the toxin-coregulated pilus isolated from Vibrio cholerae provide protection in the infant mouse experimental cholera model.
    J Infect Dis. 1990 Jun;161(6):1231-6 PMID: 1971653
  22. A method for studies of an El Tor-associated antigen of Vibrio cholerae O1.
    FEMS Microbiol Lett. 1991 Apr 15;63(2-3):179-85 PMID: 2060759
  23. Identification of a mannose-binding pilus on Vibrio cholerae El Tor.
    Microb Pathog. 1991 Dec;11(6):433-41 PMID: 1686631
  24. Epitope differences in toxin-coregulated pili produced by classical and El Tor Vibrio cholerae O1.
    Microb Pathog. 1991 Sep;11(3):179-88 PMID: 1724789
  25. Analysis of expression of toxin-coregulated pili in classical and El Tor Vibrio cholerae O1 in vitro and in vivo.
    Infect Immun. 1992 Oct;60(10):4278-84 PMID: 1356927
  26. Major outer membrane proteins of Vibrio cholerae and their role in induction of protective immunity through inhibition of intestinal colonization.
    Infect Immun. 1992 Nov;60(11):4848-55 PMID: 1398996
  27. Protection against Vibrio cholerae El Tor infection by specific antibodies against mannose-binding hemagglutinin pili.
    Infect Immun. 1992 Nov;60(11):4961-4 PMID: 1356934
  28. Identification of the flagellar antigens of Vibrio cholerae El Tor and their role in protection.
    Vaccine. 1993;11(3):372-5 PMID: 8447164
  29. Identification of a 33 kDa antigen associated with an adhesive and colonizing strain of Vibrio cholerae El Tor and its role in protection.
    Vaccine. 1993;11(3):376-82 PMID: 8447165
  30. Pili of vibrio cholerae widely distributed in serogroup O1 strains.
    Microbiol Immunol. 1993;37(1):23-8 PMID: 8097272
  31. Analysis of the roles of antilipopolysaccharide and anti-cholera toxin immunoglobulin A (IgA) antibodies in protection against Vibrio cholerae and cholera toxin by use of monoclonal IgA antibodies in vivo.
    Infect Immun. 1993 Dec;61(12):5279-85 PMID: 8225601
  32. Synergistic protective effect in rabbits of immunization with Vibrio cholerae lipopolysaccharide and toxin/toxoid.
    Infect Immun. 1976 Mar;13(3):735-40 PMID: 1270131
Article Info
Journal
Infection and immunity
Abbr.
Infect Immun
ISSN
0019-9567
Published
1994-07-00
Pages
2901-7
Language
English
Region
United States
NLM ID
0246127
PMCID
PMC302897
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]